| Twinrix |
103850 |
001 |
351(a) |
Hepatitis A & Hepatitis B (Recombinant) Vaccine |
Injection |
Intramuscular |
1ML |
Single-Dose Vial |
2001/05/11
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Campath |
103948 |
001 |
351(a) |
alemtuzumab |
Injection |
Intravenous |
30MG (10MG/ML) |
Ampule |
2001/05/07
|
Genzyme Corporation |
Disc |
Licensed |
N/A |
N/A |
| Hemofil M |
101448 |
001 |
351(a) |
Antihemophilic Factor (Human) |
For Injection |
Intravenous |
250IU |
Single-Dose Vial |
2001/03/14
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Hemofil M |
101448 |
002 |
351(a) |
Antihemophilic Factor (Human) |
For Injection |
Intravenous |
1000IU |
Single-Dose Vial |
2001/03/14
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Hemofil M |
101448 |
003 |
351(a) |
Antihemophilic Factor (Human) |
For Injection |
Intravenous |
1700IU |
Single-Dose Vial |
2001/03/14
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Hemofil M |
101448 |
004 |
351(a) |
Antihemophilic Factor (Human) |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
2001/03/14
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Imogam |
103932 |
001 |
351(a) |
Rabies Immune Globulin (Human) |
For Injection |
Intramuscular |
150IU/ML |
Single-Dose Vial |
2001/03/06
|
Sanofi Pasteur SA |
Disc |
Voluntarily Revoked |
|
N/A |
| Gonal-f |
020378 |
004 |
351(a) |
follitropin alfa |
For Injection |
Subcutaneous |
1,050IU (600IU/ML) |
Multi-Dose Vial |
2001/02/28
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Novolog |
020986 |
003 |
351(a) |
insulin aspart |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2001/01/19
|
Novo Nordisk Inc. |
Rx |
Licensed |
N/A |
N/A |
| Pegintron |
103949 |
001 |
351(a) |
peginterferon alfa-2b |
Injection |
Subcutaneous |
50MCG/0.5ML |
Single-Dose Vial |
2001/01/19
|
Merck Sharp & Dohme LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegintron |
103949 |
005 |
351(a) |
peginterferon alfa-2b |
Injection |
Subcutaneous |
50MCG/0.5ML |
Autoinjector |
2001/01/19
|
Merck Sharp & Dohme LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegintron |
103949 |
006 |
351(a) |
peginterferon alfa-2b |
Injection |
Subcutaneous |
80MCG/0.5ML |
Autoinjector |
2001/01/19
|
Merck Sharp & Dohme LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegintron |
103949 |
007 |
351(a) |
peginterferon alfa-2b |
Injection |
Subcutaneous |
80MCG/0.5ML |
Single-Dose Vial |
2001/01/19
|
Merck Sharp & Dohme LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegintron |
103949 |
008 |
351(a) |
peginterferon alfa-2b |
Injection |
Subcutaneous |
120MCG/0.5ML |
Autoinjector |
2001/01/19
|
Merck Sharp & Dohme LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegintron |
103949 |
009 |
351(a) |
peginterferon alfa-2b |
Injection |
Subcutaneous |
120MCG/0.5ML |
Single-Dose Vial |
2001/01/19
|
Merck Sharp & Dohme LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegintron |
103949 |
010 |
351(a) |
peginterferon alfa-2b |
Injection |
Subcutaneous |
150MCG/0.5ML |
Autoinjector |
2001/01/19
|
Merck Sharp & Dohme LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Pegintron |
103949 |
011 |
351(a) |
peginterferon alfa-2b |
Injection |
Subcutaneous |
150MCG/0.5ML |
Single-Dose Vial |
2001/01/19
|
Merck Sharp & Dohme LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Myobloc |
103846 |
001 |
351(a) |
rimabotulinumtoxinB |
Injection |
Intramuscular, Intraglandular |
2,500UNITS/0.5ML |
Single-Dose Vial |
2000/12/08
|
Solstice NeuroSciences, LLC |
Rx |
Licensed |
N/A |
N/A |
| Myobloc |
103846 |
002 |
351(a) |
rimabotulinumtoxinB |
Injection |
Intramuscular, Intraglandular |
5,000UNITS/ML |
Single-Dose Vial |
2000/12/08
|
Solstice NeuroSciences, LLC |
Rx |
Licensed |
N/A |
N/A |
| Myobloc |
103846 |
003 |
351(a) |
rimabotulinumtoxinB |
Injection |
Intramuscular, Intraglandular |
10,000UNITS/2ML (5,000UNITS/ML) |
Single-Dose Vial |
2000/12/08
|
Solstice NeuroSciences, LLC |
Rx |
Licensed |
N/A |
N/A |